nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advanced practice provider–led clinic for care transitions in newly diagnosed venous thromboembolism: establishment and utilization
|
Frank, Cassiopeia |
|
|
7 |
4 |
p. |
artikel |
2 |
A novel association between platelet filamin A and soluble N-ethylmaleimide sensitive factor attachment proteins regulates granule secretion
|
Golla, Kalyan |
|
|
7 |
4 |
p. |
artikel |
3 |
Anticoagulants in frail elderly patients with atrial fibrillation: a delicate balance
|
Trinks-Roerdink, Emmy M. |
|
|
7 |
4 |
p. |
artikel |
4 |
Antithrombin-lowering in hemophilia: a closer look at fitusiran
|
Young, Guy |
|
|
7 |
4 |
p. |
artikel |
5 |
Apixaban for treatment of venous thromboembolism in an obese patient with Glanzmann thrombasthenia
|
Sattler, Laurent |
|
|
7 |
4 |
p. |
artikel |
6 |
Bispecific antibodies mimicking factor VIII in hemophilia A: converting innovation to an essential medicine
|
Hermans, Cedric |
|
|
7 |
4 |
p. |
artikel |
7 |
Bleeding disorders and postpartum hemorrhage by mode of delivery: a retrospective cohort study
|
Niu, Bonnie |
|
|
7 |
4 |
p. |
artikel |
8 |
Blood coagulation test abnormalities in trauma patients detected by sonorheometry: a retrospective cohort study
|
Duclos, Gary |
|
|
7 |
4 |
p. |
artikel |
9 |
Coagulation biomarkers for ischemic stroke
|
Barakzie, Aarazo |
|
|
7 |
4 |
p. |
artikel |
10 |
Corrigendum to ‘Efficacy of emicizumab is maintained throughout dosing intervals for bleed prophylaxis’ [Research and Practice in Thrombosis and Haemostasis, Volume 7, Issue 2, February 2023, 100077]
|
Pipe, Steven W. |
|
|
7 |
4 |
p. |
artikel |
11 |
Detection of tissue factor–positive extracellular vesicles using the ExoView R100 system
|
Price, Joshua M.J. |
|
|
7 |
4 |
p. |
artikel |
12 |
Development of a computable phenotype using electronic health records for venous thromboembolism in medical inpatients: the Medical Inpatient Thrombosis and Hemostasis study
|
Thomas, Ryan M. |
|
|
7 |
4 |
p. |
artikel |
13 |
Editorial Board
|
|
|
|
7 |
4 |
p. |
artikel |
14 |
Extended half-life factor IX prophylaxis up to every 21 days in hemophilia B: a longitudinal analysis of the efficacy and safety in selected adult patients
|
Pabinger, Ingrid |
|
|
7 |
4 |
p. |
artikel |
15 |
Factor VIII inhibitors in hemophilia A treated with emicizumab: longitudinal follow-up of outcomes
|
Levy-Mendelovich, Sarina |
|
|
7 |
4 |
p. |
artikel |
16 |
Hormonal therapies and venous thrombosis: considerations for prevention and management—a reappraisal
|
Douxfils, Jonathan |
|
|
7 |
4 |
p. |
artikel |
17 |
Hormonal therapies in females with blood disorders: thrombophilia, thrombosis, hemoglobinopathies, and anemias
|
Baldwin, Maureen K. |
|
|
7 |
4 |
p. |
artikel |
18 |
Human platelets release amyloid peptides β1-40 and β1-42 in response to hemostatic, immune, and hypoxic stimuli
|
Wolska, Nina |
|
|
7 |
4 |
p. |
artikel |
19 |
Illustrated State-of-the-Art Capsules of the ISTH 2023 Congress
|
Kahn, Susan R. |
|
|
7 |
4 |
p. |
artikel |
20 |
Inside-to-outside and back to the future of megakaryopoiesis
|
Di Buduo, Christian Andrea |
|
|
7 |
4 |
p. |
artikel |
21 |
Issue Information
|
|
|
|
7 |
4 |
p. |
artikel |
22 |
Multicolor flow cytometry in clinical samples for platelet signaling assessment
|
Garcia, Cedric |
|
|
7 |
4 |
p. |
artikel |
23 |
Outcomes in infants with unprovoked venous thromboembolism: A retrospective cohort study
|
Whitworth, Hilary |
|
|
7 |
4 |
p. |
artikel |
24 |
Patients’ and health care providers’ perspectives on quality of hemophilia care in the Netherlands: a questionnaire and interview study
|
Brands, Martijn R. |
|
|
7 |
4 |
p. |
artikel |
25 |
Pharmacokinetics of recombinant factor VIII in adults with severe hemophilia A: fixed-sequence single-dose study of octocog alfa, rurioctocog alfa pegol, and efanesoctocog alfa
|
Lissitchkov, Toshko |
|
|
7 |
4 |
p. |
artikel |
26 |
PIK3R3 is a candidate regulator of platelet count in people of Bangladeshi ancestry
|
Burley, Kate |
|
|
7 |
4 |
p. |
artikel |
27 |
Plasma extracellular vesicle test sample to standardize flow cytometry measurements
|
Bettin, Britta |
|
|
7 |
4 |
p. |
artikel |
28 |
Platelet versus plasma CXCL14, coronary artery disease, and clinical outcomes
|
Schories, Christoph |
|
|
7 |
4 |
p. |
artikel |
29 |
Poststroke venous thromboembolism and neutrophil activation: an illustrated review
|
Dhanesha, Nirav |
|
|
7 |
4 |
p. |
artikel |
30 |
Preventing swarm detection in extracellular vesicle flow cytometry: a clinically applicable procedure
|
Buntsma, Naomi C. |
|
|
7 |
4 |
p. |
artikel |
31 |
Regulation of megakaryo/thrombopoiesis by endosomal toll-like receptor 7 and 8 activation of CD34+ cells in a viral infection model
|
Rodríguez, Camila Sofía |
|
|
7 |
4 |
p. |
artikel |
32 |
Renal transplant and hemostasis: early postoperative changes in recipients and donors
|
Kohli, Ruchika |
|
|
7 |
4 |
p. |
artikel |
33 |
Response to “Clinically relevant increases in the international normalized ratio and model of end-stage liver disease score by therapeutic doses of direct oral anticoagulants in patients with cirrhosis”
|
Patel, Jignesh P. |
|
|
7 |
4 |
p. |
artikel |
34 |
Revisiting important issues in cancer and atrial fibrillation
|
Wang, Tzu-Fei |
|
|
7 |
4 |
p. |
artikel |
35 |
RPTH year 6 article collection
|
Cushman, Mary |
|
|
7 |
4 |
p. |
artikel |
36 |
Spatial transcriptomics of murine bone marrow megakaryocytes at single-cell resolution
|
Tilburg, Julia |
|
|
7 |
4 |
p. |
artikel |
37 |
The impact of PROS1 mutation position on thrombotic risk in protein S–deficient patients
|
Fenclova, Tereza |
|
|
7 |
4 |
p. |
artikel |
38 |
The intracellular and plasma membrane pools of phosphatidylinositol-4-monophosphate control megakaryocyte maturation and proplatelet formation
|
Bura, Ana |
|
|
7 |
4 |
p. |
artikel |
39 |
The right time to measure anti-Xa activity in critical illness: pharmacokinetics of therapeutic dose nadroparin
|
Sytema, Jelmer G. |
|
|
7 |
4 |
p. |
artikel |
40 |
Thrombus composition and thrombolysis resistance in stroke
|
Ho-Tin-Noé, Benoit |
|
|
7 |
4 |
p. |
artikel |
41 |
Venous thromboembolism secondary to hospitalization for COVID-19: patient management and long-term outcomes
|
Ageno, Walter |
|
|
7 |
4 |
p. |
artikel |
42 |
von Willebrand factor, ADAMTS-13, and thrombospondin 1 in relation to clinical outcomes in elderly patients with a recent myocardial infarction
|
Warlo, Ellen M.K. |
|
|
7 |
4 |
p. |
artikel |
43 |
Von Willebrand factor and the thrombophilia of severe COVID-19: in situ evidence from autopsies
|
van den Berg, Jana |
|
|
7 |
4 |
p. |
artikel |